| LC control no. | n 82057300 |
|---|---|
| Descriptive conventions | rda |
| Personal name heading | Jordan, V. Craig (Virgil Craig) |
| Variant(s) | Jordan, Virgil Craig Jordan, V. C. (Virgil Craig) Jordan, Craig, 1947-2024 |
| Associated country | United States |
| Birth date | 1947-07-25 |
| Death date | 2024-06-09 |
| Affiliation | University of Texas M.D. Anderson Cancer Center |
| Profession or occupation | Pharmacologists |
| Found in | Non-steroidal antioestrogens, 1981 (a.e.) t.p. (V. Craig Jordan, Ludwig Inst. for Cancer Res., Inselspital, Univ. Bern) Aus CIP data (Jordan, V. Craig (Virgil Craig)) Long-term tamoxifen treatment for breast cancer, c1994: CIP t.p. (V. Craig Jordan) data sheet (b. July 25, 1947) NLM files, Nov. 27, 2013 (usage: V. Craig Jordan; V.C. Jordan; Craig Jordan) MD Anderson Cancer Center website, 5 Aug. 2024 (V. Craig Jordan; died June 9, 2024, at his home in Houston; pharmacologist; professor at The University of Texas MD Anderson Cancer Center who discovered Selective Estrogen Receptor Modulators (SERMs) and developed breakthrough breast cancer treatments; known as the "father of tamoxifen") <https://www.mdanderson.org/newsroom/md-anderson-celebrates-the-life-and-legacy-of-v-craig-jordan-PhD.h00-159698334.html> |
| Associated language | eng |
| Invalid LCCN | n 93804476 |
 |  |  |
View this record in: MARCXML | LC Authorities & Vocabularies | VIAF (Virtual International Authority File)
